Neogenomics Inc (NEO) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NEO.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 122 days, NEO's average price target has gone up $10.44.
NEO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NEO as an investment opportunity.
- Neogenomics Inc's number of analysts covering the stock is higher than 75.71% of all US stocks.
- The upside potential (average analyst target price relative to current price) of NEO is higher than 22.43% of Healthcare stocks.
- NEO has a greater average analyst price target than 75.64% of Healthcare stocks.
- The variance in analysts' estimates of NEO is less than 34.62% of all US stocks.
- NEO has a higher NA than just about none of of all US stocks.
Make investment decisions regarding NEO using the data that counts. Try POWR Ratings for free.